- Home
- KNOP vs ALEC Comparison
KNOP vs ALEC Comparison
Compare KNOP & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNOP
- ALEC
- Stock Information
- Founded
- KNOP 2013
- ALEC 2013
- Country
- KNOP United Kingdom
- ALEC United States
- Employees
- KNOP N/A
- ALEC N/A
- Industry
- KNOP Marine Transportation
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KNOP Consumer Discretionary
- ALEC Health Care
- Exchange
- KNOP Nasdaq
- ALEC Nasdaq
- Market Cap
- KNOP 213.1M
- ALEC 232.6M
- IPO Year
- KNOP 2013
- ALEC 2019
- Fundamental
- Price
- KNOP $5.58
- ALEC $1.96
- Analyst Decision
- KNOP
- ALEC Buy
- Analyst Count
- KNOP 0
- ALEC 6
- Target Price
- KNOP N/A
- ALEC $11.75
- AVG Volume (30 Days)
- KNOP 97.9K
- ALEC 2.0M
- Earning Date
- KNOP 12-04-2024
- ALEC 11-06-2024
- Dividend Yield
- KNOP 1.88%
- ALEC N/A
- EPS Growth
- KNOP N/A
- ALEC N/A
- EPS
- KNOP N/A
- ALEC N/A
- Revenue
- KNOP $299,790,000.00
- ALEC $61,508,000.00
- Revenue This Year
- KNOP $7.66
- ALEC N/A
- Revenue Next Year
- KNOP $1.75
- ALEC $71.71
- P/E Ratio
- KNOP N/A
- ALEC N/A
- Revenue Growth
- KNOP 4.75
- ALEC N/A
- 52 Week Low
- KNOP $4.94
- ALEC $1.85
- 52 Week High
- KNOP $9.11
- ALEC $8.90
- Technical
- Relative Strength Index (RSI)
- KNOP 32.07
- ALEC 26.45
- Support Level
- KNOP $5.36
- ALEC $1.85
- Resistance Level
- KNOP $5.98
- ALEC $2.50
- Average True Range (ATR)
- KNOP 0.23
- ALEC 0.17
- MACD
- KNOP -0.02
- ALEC 0.02
- Stochastic Oscillator
- KNOP 17.50
- ALEC 13.69
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.